// STATE LEGISLATION TRACKER

Missouri HB 2260: Creates provisions relating to pharmacists' authority to dispense insulin

⚖️ POSITIVE for peptide users 👤 LOW user impact 📜 Status: In committee

State: Missouri
Bill: HB 2260
Session: 2026
Filed: 2025-12-08
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

HB2260 appears to let Missouri pharmacists dispense an emergency supply of insulin without a current prescription when certain conditions are met. It has little direct effect on the broader peptide ecosystem because it is about insulin access, not compounded peptides, off-label prescribing, telehealth, or clinic scope rules.

Key Points

Could help insulin users avoid gaps when a prescription cannot be renewed in time
Does not appear to legalize or restrict compounded peptide prescribing
Does not appear to change telehealth prescribing rules
Does not appear to change NP or naturopathic scope of practice
No clear effect on 503A or 503B peptide compounding

What to Watch For

✓

Opportunity Emergency insulin access may improve for patients who run out before seeing a prescriber.

Note This looks limited to insulin and should not be read as a broader peptide access bill.

Concern Rule details could matter if pharmacists must document prior prescriptions or clinical risk.

Where the Bill Stands

The bill has been referred to the House Emerging Issues Committee and has not passed a chamber.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-10-02 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws